Sterile Injectable Contract Manufacturing Market is anticipated to expand from $21.4 billion in 2024 to $47.4 billion by 2034, growing at a CAGR of approximately 8.3%.
Market Overview The Sterile Injectable Contract Manufacturing Market continues to gain momentum as pharmaceutical and biotechnology companies increasingly outsource sterile drug production to specialized partners. …